Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.
Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe page now displays 'Results Submitted' instead of 'No Results Posted'. This indicates that study results have been submitted for the record.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedLocations sections were updated to add sites in New South Wales, Rio Grande do Sul, São Paulo, Abruzzo, Campania, Emilia-Romagna, Lazio, Tuscany, Veneto, Mexico City, Barcelona, Cantabria, and La Coruña, while several other locations were removed.SummaryDifference0.8%
- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check57 days agoChange DetectedRemoved the notice about government funding lapse from the page, and the operating-status information formerly shown at cc.nih.gov and opm.gov is no longer displayed. The core study details and trial design remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check78 days agoChange DetectedThe page shows a new last update date and minor administrative edits; core sections such as eligibility criteria and primary outcomes appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check100 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%
Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.